Evaluation of predictive value of olfactory dysfunction, as a screening tool for COVID‐19

OBJECTIVES: At the end of 2019, SARS‐CoV‐2 was identified, the one responsible for the COVID‐19 disease. Between a 5.1% and a 98% of COVID‐19 patients present some form of alteration in their sense of smell. The objective of this study is to determine the diagnostic yield of the smell dysfunction as...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero‐Gameros, Carlos Alfonso, Waizel‐Haiat, Salomón, Mendoza‐Zubieta, Victoria, Anaya‐Dyck, Alfredo, López‐Moreno, Mayra Alejandra, Colin‐Martinez, Tania, Martínez‐Ordaz, José Luis, Ferat‐Osorio, Eduardo, Vivar‐Acevedo, Eulalio, Vargas‐Ortega, Guadalupe, Wacher Rodarte, Niels H., González‐Virla, Baldomero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Allergy, Rhinology, and Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752039/
https://www.ncbi.nlm.nih.gov/pubmed/33364386
http://dx.doi.org/10.1002/lio2.482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752039/
https://www.ncbi.nlm.nih.gov/pubmed/33364386
http://dx.doi.org/10.1002/lio2.482

Ejemplares similares